We thus provide mechanistic insights which may explain an earlier study where low dose CA-4 application (2 mg/kg) in a rat model of intrahepatic colon carcinoma acted synergistically with anti-cancer immunization without changing the tumor’s vascular density (Badn et al, 2006). The gene discussed is CA4; the disease is neoplasm.